Vor Biopharma Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $107.9M | $169.9M | $396.5M | $160.5M | $190.6M | $50.0M | $81.9M | $52.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $475.1M | $500.8M | $458.1M | $172.5M | $204.9M | $64.8M | $96.5M | $67.3M |
| Property, Plant & Equipment | $648.0K | $565.0K | $533.0K | $271.0K | $0 | $6.0M | $6.6M | $7.5M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $481.1M | $506.7M | $464.1M | $176.2M | $205.4M | $109.3M | $142.9M | $116.0M |
| Liabilities | ||||||||
| Accounts Payable | $4.0M | $1.0M | $5.1M | $885.0K | $669.0K | $3.7M | $1.5M | $1.3M |
| Total Current Liabilities | $24.8M | $16.1M | $25.2M | $18.8M | $58.8M | $16.7M | $18.6M | $14.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $681.3M | $657.2M | $628.4M | $2.40B | $1.71B | $43.2M | $46.2M | $43.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.44B | $-1.37B | $-1.15B | $-2.88B | $-2.06B | $-489.5M | $-457.0M | $-426.3M |
| Total Stockholders' Equity | $-200.2M | $-150.4M | $-164.3M | $-2.23B | $-1.51B | $66.1M | $96.7M | $73.0M |